Odyssey Health, Inc. (ODYY)
OTCMKTS · Delayed Price · Currency is USD
0.0175
0.00 (0.00%)
May 29, 2026, 12:52 PM EST
Odyssey Health Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
1.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | - | - | - |
| Jul 31, 2024 | - | - | - |
| Jul 31, 2023 | - | - | - |
| Jul 31, 2022 | - | - | - |
| Jul 31, 2021 | - | - | - |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sonendo | 31.70M |
| STRATA Skin Sciences | 30.70M |
| Fuse Medical | 18.40M |
| Biotricity | 15.45M |
| Escalon Medical | 11.45M |
| Vycor Medical | 1.89M |
| CYduct Diagnostics | 344.78K |
| REMSleep Holdings | 16.72K |
Odyssey Health News
- 5 weeks ago - Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth - PRNewsWire
- 6 months ago - Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million - GlobeNewsWire
- 8 months ago - Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace - GlobeNewsWire
- 9 months ago - Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device - GlobeNewsWire
- 2 years ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 2 years ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire